Hello Alex,
This post should have read to Alex from Cindy Powell, instead of from Cindy Powell to Cindy Powell. (Kind of sounds like I am talking to myself doesn't it!)
The following was just released on P.R. Newswire October 16. 1996.
"Thomas M. Asher PHD was just recently named to the companies scientific advisory board. Asher recieved his doctorate from the University of London's Imperial College of Science and Technology in "mechanisms of antibiosis," which involves the eradication of microbes in general. Following a distinquished career with Centers for Disease Control, Asher served on the executive management teams of Hyland Laboratories, which was then the largest manufacturer of fractionated blood products in the United States, and Immuno-Science, a manufacturer of blood related biological and diagnostics products.
During his 17 year tenure with Hemacare, Asher successfully led efforts to provide specialized blood components, such as concentrated platelets and immunoglobulins, to the health care industry. In addition, he has served on the board of directors for a number of national and regional biotechnology organizations.
Having recently recieved notice of allowance from the U.S. Patent and Trademark Office for the use of MDI-P in the sterilization of blood fractionated products, we wholeheartedly welcome Tom to MDL's advisory board. His scientific expertise, combined with his knowledge of bringing whole blood related products to market, represents a tremendous addition. We look forward to working with Tom as we pursue the commercialization of MDI-P for the blood product sterilization industry."
Sounds pretty good doesn't it? They have some pretty impressive people on their scientific advisory board. Give the company a call, they are very generous in answering any questions you may have. (Company phone number is posted on original thread.)
Cindy |
